Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sarepta Therapeutics, Inc. SRPT

Full chart Compare
Set alert

Price alert · SRPT

All alert types
17.82 USD +0.25 (+1.42%)

At closeNov 6, 2026, 7:48 PM EST

17.82 0.00 0.00%

After hours · Nov 6, 7:48 PM ET

17.52 Day range 18.77
14.86 52-week range 23.83
YTD
-17.19%
1 year
+1.02%

Financial health

Altman Z-Score

0.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -3.0×
FY 2016: -5.0×FY 2017: -64.7×FY 2018: -20.0×FY 2019: -13.3×FY 2020: -24.0×FY 2021: -17.5×FY 2022: -16.1×FY 2023: -16.6×FY 2024: 49.2×FY 2025: -3.0×
FY 2016 5y median -16.1× FY 2025
P/S 1.0×
FY 2016: 246×FY 2017: 21.2×FY 2018: 24.0×FY 2019: 24.9×FY 2020: 24.6×FY 2021: 10.4×FY 2022: 12.2×FY 2023: 7.2×FY 2024: 6.1×FY 2025: 1.0×
FY 2016 5y median 7.2× FY 2025
P/B 2.0×
FY 2016: 4.0×FY 2017: 4.1×FY 2018: 7.0×FY 2019: 11.6×FY 2020: 17.4×FY 2021: 7.9×FY 2022: 29.5×FY 2023: 10.4×FY 2024: 7.6×FY 2025: 2.0×
FY 2016 5y median 7.9× FY 2025
P/FCF -7.3×
FY 2016: -5.3×FY 2017: -12.9×FY 2018: -16.0×FY 2019: -18.4×FY 2020: 526×FY 2021: -15.2×FY 2022: -31.7×FY 2023: -15.1×FY 2024: -32.8×FY 2025: -7.3×
FY 2016 5y median -15.2× FY 2025
EV/EBITDA -3.8×
FY 2016: -4.7×FY 2017: -89.3×FY 2018: -23.0×FY 2019: -14.3×FY 2020: -28.4×FY 2021: -20.0×FY 2022: -20.2×FY 2023: -21.8×FY 2024: 37.2×FY 2025: -3.8×
FY 2016 5y median -20.0× FY 2025
EV/Sales 1.1×
FY 2016: 227×FY 2017: 20.1×FY 2018: 24.2×FY 2019: 24.7×FY 2020: 23.9×FY 2021: 9.1×FY 2022: 12.9×FY 2023: 7.9×FY 2024: 6.2×FY 2025: 1.1×
FY 2016 5y median 7.9× FY 2025
FCF Yield -13.6%
FY 2016: -18.9%FY 2017: -7.7%FY 2018: -6.3%FY 2019: -5.4%FY 2020: 0.2%FY 2021: -6.6%FY 2022: -3.2%FY 2023: -6.6%FY 2024: -3.1%FY 2025: -13.6%
FY 2016 5y median -6.6% FY 2025

Profitability

Gross Margin 59.9%
FY 2016: 97.6%FY 2017: 95.2%FY 2018: 88.6%FY 2019: 85.1%FY 2020: 88.3%FY 2021: 86.2%FY 2022: 85.0%FY 2023: 87.9%FY 2024: 83.2%FY 2025: 59.9%
FY 2016 5y median 85.0% FY 2025
Operating Margin -29.9%
FY 2016: -4920.3%FY 2017: -111.0%FY 2018: -114.1%FY 2019: -185.3%FY 2020: -104.5%FY 2021: -65.5%FY 2022: -57.5%FY 2023: -21.5%FY 2024: 11.5%FY 2025: -29.9%
FY 2016 5y median -29.9% FY 2025
Net Margin -32.5%
FY 2016: -4930.2%FY 2017: -32.8%FY 2018: -120.2%FY 2019: -187.8%FY 2020: -102.6%FY 2021: -59.7%FY 2022: -75.4%FY 2023: -43.1%FY 2024: 12.4%FY 2025: -32.5%
FY 2016 5y median -43.1% FY 2025
ROE -62.5%
FY 2016: -79.4%FY 2017: -6.4%FY 2018: -35.1%FY 2019: -87.4%FY 2020: -72.7%FY 2021: -45.1%FY 2022: -182.7%FY 2023: -62.4%FY 2024: 15.4%FY 2025: -62.5%
FY 2016 5y median -62.4% FY 2025
ROIC -29.0%
FY 2016: -74.3%FY 2017: -14.0%FY 2018: -23.4%FY 2019: -45.1%FY 2020: -21.8%FY 2021: -17.0%FY 2022: -21.2%FY 2023: -9.8%FY 2024: 6.1%FY 2025: -29.0%
FY 2016 5y median -17.0% FY 2025
ROA -21.3%
FY 2016: -63.0%FY 2017: -3.9%FY 2018: -22.0%FY 2019: -39.2%FY 2020: -18.6%FY 2021: -13.3%FY 2022: -22.5%FY 2023: -16.4%FY 2024: 5.9%FY 2025: -21.3%
FY 2016 5y median -16.4% FY 2025

Growth (YoY)

Revenue 15.6%
FY 2016: 332.6%FY 2017: 2751.6%FY 2018: 94.7%FY 2019: 26.5%FY 2020: 41.8%FY 2021: 30.0%FY 2022: 32.9%FY 2023: 33.3%FY 2024: 53.0%FY 2025: 15.6%
FY 2016 FY 2025
Operating Income -401.6%
FY 2016: -21.1%FY 2017: 35.7%FY 2018: -100.2%FY 2019: -105.3%FY 2020: 20.0%FY 2021: 18.5%FY 2022: -16.6%FY 2023: 50.1%FY 2024: 181.4%FY 2025: -401.6%
FY 2016 FY 2025
EPS (diluted) -404.7%
FY 2016: -5.6%FY 2017: 84.3%FY 2018: -534.9%FY 2019: -77.8%FY 2020: 26.8%FY 2021: 27.6%FY 2022: -55.9%FY 2023: 27.8%FY 2024: 140.3%FY 2025: -404.7%
FY 2016 FY 2025
Free Cash Flow 12.8%
FY 2016: -63.8%FY 2017: -0.2%FY 2018: -78.9%FY 2019: -13.9%FY 2020: 104.9%FY 2021: -2006.5%FY 2022: 25.8%FY 2023: -64.5%FY 2024: 40.0%FY 2025: 12.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.3×
FY 2016: 5.0×FY 2017: 13.9×FY 2018: 8.2×FY 2019: 5.5×FY 2020: 6.0×FY 2021: 5.8×FY 2022: 4.1×FY 2023: 3.9×FY 2024: 4.2×FY 2025: 2.3×
FY 2016 5y median 4.1× FY 2025
Quick Ratio 1.5×
FY 2016: 4.8×FY 2017: 13.0×FY 2018: 7.5×FY 2019: 4.9×FY 2020: 5.4×FY 2021: 5.3×FY 2022: 3.8×FY 2023: 3.5×FY 2024: 3.2×FY 2025: 1.5×
FY 2016 5y median 3.5× FY 2025
Debt / Equity 0.9×
FY 2016: 0.0×FY 2017: 0.5×FY 2018: 0.4×FY 2019: 0.9×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 4.2×FY 2023: 1.6×FY 2024: 0.9×FY 2025: 0.9×
FY 2016 5y median 1.2× FY 2025
Net Debt / EBITDA -0.4×
FY 2016: 0.4×FY 2017: 4.9×FY 2018: -0.2×FY 2019: 0.1×FY 2020: 0.9×FY 2021: 3.0×FY 2022: -1.1×FY 2023: -2.1×FY 2024: 0.8×FY 2025: -0.4×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -67.6×
FY 2016: -141×FY 2017: -29.7×FY 2018: -10.2×FY 2019: -23.0×FY 2020: -9.4×FY 2021: -7.2×FY 2022: -10.1×FY 2023: -12.2×FY 2024: 11.9×FY 2025: -67.6×
FY 2016 5y median -10.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31